ConductScience.org, home

Paper18281925

Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses.

Jones HP and 3 others. Cancer Immun, 2008. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses. Papers, record 18281925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18281925

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses.
PubMed
Journal
Cancer Immun
PubMed
Year
2008
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2021-10-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jones HPHarlan P
2Wang YCYi-Chong
3Aldridge BBeau
4Weiss JMJay M

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
B-LymphocytesMajor topic
Immunologic SurveillanceMajor topic
Lung NeoplasmsMajor topic
Neoplasms, ExperimentalMajor topic
SpleenMajor topic
Animals
B7-1 Antigen
B7-2 Antigen
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Enzyme-Linked Immunosorbent Assay
Female
Interferon-gamma
Killer Cells, Natural
Lymphocytes, Tumor-Infiltrating
Male
Rats
Rats, Inbred F344

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA087923NCI NIH HHSUnited StatesR01CA087923PubMed

Source NIH RePORTER

Download CSV of grants

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17553886B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma.Cell Immunol1995https://conductscience.org/library/papers/7553886PubMed
28885864Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)Immunity1996https://conductscience.org/library/papers/8885864PubMed
312154358Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.Nat Immunol2002https://conductscience.org/library/papers/12154358PubMed
410354375Interaction between B.7 and CD28 costimulatory molecules is essential for the activation of effector function mediating spontaneous tumour regression.Scand J Immunol1999https://conductscience.org/library/papers/10354375PubMed
514707050Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells.J Immunol2004https://conductscience.org/library/papers/14707050PubMed
610394132Alteration of signal-transducing molecules and phenotypical characteristics in peripheral blood lymphocytes from gastric carcinoma patients.Pathobiology1999https://conductscience.org/library/papers/10394132PubMed
79010717The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response.Immunol Rev1996https://conductscience.org/library/papers/9010717PubMed
88635191Specific antitumor activity of tumor-infiltrating lymphocytes expanded first in a culture with both anti-CD3 monoclonal antibody and activated B cells and then in a culture with interleukin-2.Cancer Immunol Immunother1995https://conductscience.org/library/papers/8635191PubMed
912176894IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide.Blood2002https://conductscience.org/library/papers/12176894PubMed
101894371Specific and nonspecific antibody responses in different segments of the respiratory tract in rats infected with Mycoplasma pulmonis.Infect Immun1991https://conductscience.org/library/papers/1894371PubMed
117540948Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity.Cancer Res1995https://conductscience.org/library/papers/7540948PubMed
1211970991A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo.J Immunol2002https://conductscience.org/library/papers/11970991PubMed
1317183544Tumor-derived factors impaired motility and immune functions of dendritic cells through derangement of biophysical characteristics and reorganization of cytoskeleton.Cell Motil Cytoskeleton2007https://conductscience.org/library/papers/17183544PubMed
142492576Regulation of B lymphocytes by natural killer cells. Role of IFN-gamma.J Immunol1989https://conductscience.org/library/papers/2492576PubMed
1511591779The pulmonary environment promotes Th2 cell responses after nasal-pulmonary immunization with antigen alone, but Th1 responses are induced during instances of intense immune stimulation.J Immunol2001https://conductscience.org/library/papers/11591779PubMed
1616049975Exploitation of interleukin-18 by gastric cancers for their growth and evasion of host immunity.Int J Cancer2006https://conductscience.org/library/papers/16049975PubMed
179585241B cells inhibit induction of T cell-dependent tumor immunity.Nat Med1998https://conductscience.org/library/papers/9585241PubMed
1812244160Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells.J Immunol2002https://conductscience.org/library/papers/12244160PubMed
1912149421Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors.J Leukoc Biol2002https://conductscience.org/library/papers/12149421PubMed
203871818Direct evidence for the role of LGL in the inhibition of experimental tumor metastases.J Immunol1985https://conductscience.org/library/papers/3871818PubMed

See all 33 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
41285707Targeting tumour-infiltrating B cells: mechanisms and advances in cancer therapy.Cell Death Dis2025https://conductscience.org/library/papers/41285707PubMed
41019045Tumor-infiltrating lymphocytes and tumor-associated macrophages in cancer immunoediting: a targetable therapeutic axis.Front Immunol2025https://conductscience.org/library/papers/41019045PubMed
40959278Activated B cells modulate the maturation of MDSCs via CD36-dependent MHC-II transfer to orchestrate CD4+ Th1-dominant antitumor immunity after cryo-thermal therapy.Int J Biol Sci2025https://conductscience.org/library/papers/40959278PubMed
38391970Regulatory B Cells-Immunopathological and Prognostic Potential in Humans.Cells2024https://conductscience.org/library/papers/38391970PubMed
37215990B cells in tumor metastasis: friend or foe?Int J Biol Sci2023https://conductscience.org/library/papers/37215990PubMed
36389757Construction of a B cell-related gene pairs signature for predicting prognosis and immunotherapeutic response in non-small cell lung cancer.Front Immunol2022https://conductscience.org/library/papers/36389757PubMed
36175603Clinical relevance and therapeutic aspects of professional antigen-presenting cells in lung cancer.Med Oncol2022https://conductscience.org/library/papers/36175603PubMed
35563678Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children.Int J Mol Sci2022https://conductscience.org/library/papers/35563678PubMed
35152302Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma.Cancer Immunol Immunother2022https://conductscience.org/library/papers/35152302PubMed
33139907Tumor-infiltrating lymphocytes in the immunotherapy era.Cell Mol Immunol2021https://conductscience.org/library/papers/33139907PubMed
33098370Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma.Cancer Med2020https://conductscience.org/library/papers/33098370PubMed
29628498Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer.Cell Mol Immunol2019https://conductscience.org/library/papers/29628498PubMed
29153616A role for B cells in facilitating defense against an NK cell-sensitive lung metastatic tumor is revealed by stress.J Neuroimmunol2017https://conductscience.org/library/papers/29153616PubMed
28626234B cell regulation in cancer and anti-tumor immunity.Cell Mol Immunol2017https://conductscience.org/library/papers/28626234PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18281925

GET https://conductscience.org/api/papers/v1/18281925/references?page=2